Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 14

Pharmacogenomics and Personalized Medicine


Archive: Volume 14, 2021

Relationship Between KCNQ1 Polymorphism and Type 2 Diabetes Risk in Northwestern China

Xu J, Zhang W, Song W, Cui J, Tian Y, Chen H, Huang P, Yang S, Wang L, He X, Wang L, Shi B, Cui W

Pharmacogenomics and Personalized Medicine 2021, 14:1731-1751

Published Date: 31 December 2021

Systematic Pan-Cancer Analysis of KIF23 and a Prediction Model Based on KIF23 in Clear Cell Renal Cell Carcinoma (ccRCC)

Bai X, Cao Y, Yan X, Tuoheti K, Du G, Chen Z, Wu H, Guo L, Liu T

Pharmacogenomics and Personalized Medicine 2021, 14:1717-1729

Published Date: 30 December 2021

Fragile X Premutation: Medications, Therapy and Lifestyle Advice

Sodhi DK, Hagerman R

Pharmacogenomics and Personalized Medicine 2021, 14:1689-1699

Published Date: 29 December 2021

Isotretinoin Induced Hyperlipidemia and Impact of Leptin Gene rs 7799039 Polymorphism in Safety of Acne Patients

Mohamed AA, Hassnine A, Elsayed A, Montaser M, Ismail Y, El-Demery A, Sultan E, Abdel Aziz RS, Eldemiry E, Hagag R, El-Kholy AA, Salah E

Pharmacogenomics and Personalized Medicine 2021, 14:1679-1687

Published Date: 24 December 2021

Combined GSTT1 Null, GSTM1 Null and XPD Lys/Lys Genetic Polymorphisms and Their Association with Increased Risk of Chronic Myeloid Leukemia

Abdalhabib EK, Jackson DE, Alzahrani B, Elfaki EM, Hamza A, Alanazi F, Ali EI, Algarni A, Ibrahim IK, Saboor M

Pharmacogenomics and Personalized Medicine 2021, 14:1661-1667

Published Date: 22 December 2021

Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China

Wang Y, Peng L, Lu H, Zhang Z, Xing S, Li D, He C, Jin T, Wang L

Pharmacogenomics and Personalized Medicine 2021, 14:1647-1660

Published Date: 17 December 2021

RF1 Gene Mutation in Familial Hemophagocytic Lymphohistiocytosis 2: A Family Report and Literature Review

Shi Y, Qiao Z, Bi X, Zhang C, Fu J, Jia Y, Yang G

Pharmacogenomics and Personalized Medicine 2021, 14:1637-1645

Published Date: 16 December 2021

The Landscape of Clinical Implementation of Pharmacogenetic Testing in Central China: A Single-Center Study

Zhang J, Qi G, Han C, Zhou Y, Yang Y, Wang X, Liu S, Zhang X

Pharmacogenomics and Personalized Medicine 2021, 14:1619-1628

Published Date: 14 December 2021

Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature

White C, Scott RJ, Paul C, Ziolkowski A, Mossman D, Ackland S

Pharmacogenomics and Personalized Medicine 2021, 14:1603-1617

Published Date: 9 December 2021

Apolipoprotein E Gene Polymorphism and Coronary Artery Disease Risk Among Patients in Northwest China

Ma W, Ren X, Zhang L, Dong H, Lu X, Feng W

Pharmacogenomics and Personalized Medicine 2021, 14:1591-1599

Published Date: 7 December 2021

Identification of a Novel VPS13B Mutation in a Chinese Patient with Cohen Syndrome by Whole-Exome Sequencing

Hu X, Huang T, Liu Y, Zhang L, Zhu L, Peng X, Zhang S

Pharmacogenomics and Personalized Medicine 2021, 14:1583-1589

Published Date: 4 December 2021

MicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction

Rytkin E, Mirzaev K, Bure I, Akmalova K, Abdullaev S, Kachanova A, Smirnov V, Grishina E, Lyakhova N, Aleshkovich E, Saribekian A, Andreev D, Shabunin A, Sychev D

Pharmacogenomics and Personalized Medicine 2021, 14:1575-1582

Published Date: 2 December 2021

Genetic Variant of PP2A Subunit Gene Confers an Increased Risk of Primary Liver Cancer in Chinese

Wang Y, Huang Q, Huang X, Zhao H, Guan B, Ban K, Zhu X, Ma Z, Tang Y, Su Z, Nong Q

Pharmacogenomics and Personalized Medicine 2021, 14:1565-1574

Published Date: 1 December 2021

Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma

Zhang L, Luo Y, Cheng T, Chen J, Yang H, Wen X, Jiang Z, Li H, Pan C

Pharmacogenomics and Personalized Medicine 2021, 14:1549-1563

Published Date: 30 November 2021

Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients

Cheng F, Li Q, Wang J, Hu M, Zeng F, Wang Z, Zhang Y

Pharmacogenomics and Personalized Medicine 2021, 14:1463-1474

Published Date: 19 November 2021

Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice

Venkatachalapathy P, Padhilahouse S, Sellappan M, Subramanian T, Kurian SJ, Miraj SS, Rao M, Raut AA, Kanwar RK, Singh J, Khadanga S, Mondithoka S, Munisamy M

Pharmacogenomics and Personalized Medicine 2021, 14:1441-1455

Published Date: 13 November 2021

ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer

Wang X, Li Y, Fu J, Zhou K, Wang T

Pharmacogenomics and Personalized Medicine 2021, 14:1425-1440

Published Date: 10 November 2021

Identification of Two Novel DNAAF2 Variants in Two Consanguineous Families with Primary Ciliary Dyskinesia

Lu C, Yang D, Lei C, Wang R, Guo T, Luo H

Pharmacogenomics and Personalized Medicine 2021, 14:1415-1423

Published Date: 10 November 2021

Variation of Genomic Sites Associated with Severe Covid-19 Across Populations: Global and National Patterns

Balanovsky O, Petrushenko V, Mirzaev K, Abdullaev S, Gorin I, Chernevskiy D, Agdzhoyan A, Balanovska E, Kryukov A, Temirbulatov I, Sychev D

Pharmacogenomics and Personalized Medicine 2021, 14:1391-1402

Published Date: 4 November 2021

Exploring the Epigenetic Regulatory Role of m6A-Associated SNPs in Type 2 Diabetes Pathogenesis

Chen M, Lin W, Yi J, Zhao Z

Pharmacogenomics and Personalized Medicine 2021, 14:1369-1378

Published Date: 27 October 2021

Pattern Recognition Molecules of Lectin Complement Pathway in Ischemic Stroke

Tsakanova G, Stepanyan A, Steffensen R, Soghoyan A, Jensenius JC, Arakelyan A

Pharmacogenomics and Personalized Medicine 2021, 14:1347-1368

Published Date: 21 October 2021

H/ACA snoRNP Gene Family as Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma

Zhang M, Zhao W, Liu S, Liu H, Liu L, Peng Q, Du C, Jiang N

Pharmacogenomics and Personalized Medicine 2021, 14:1331-1345

Published Date: 19 October 2021

NUDT15 c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy

Pai AA, Mohan A, Benjamin ESB, Illangeswaran RSS, Xavier Raj I, Janet NB, Arunachalam AK, Kavitha ML, Kulkarni U, Devasia AJ, Fouzia NA, Abraham A, Srivastava A, George B, Mathews V, Korula A, Balasubramanian P

Pharmacogenomics and Personalized Medicine 2021, 14:1303-1313

Published Date: 2 October 2021

Nuclear Pore Glycoprotein 62 Genetic Variant rs9523 is Associated with Clinical Outcomes of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Adenocarcinoma Patients

Park JE, Hong MJ, Lee SY, Lee JH, Choi JE, Kang HG, Do SK, Jeong JY, Shin KM, Lee WK, Choi SH, Lee YH, Seo HW, Yoo SS, Lee J, Cha SI, Kim CH, Park JY

Pharmacogenomics and Personalized Medicine 2021, 14:1291-1302

Published Date: 1 October 2021

Analysis of Very Important Pharmacogenomics Variants in the Chinese Lahu Population

Cheng Y, Li Q, Yang X, Ding H, Chen W, Dai R, Zhang C

Pharmacogenomics and Personalized Medicine 2021, 14:1275-1289

Published Date: 1 October 2021

miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer

Romero-Lorca A, Novillo A, Gaibar M, Gilsanz MF, Galán M, Beltrán L, Antón B, Malón D, Moreno A, Fernández-Santander A

Pharmacogenomics and Personalized Medicine 2021, 14:1263-1273

Published Date: 29 September 2021

The Effects of WISP1 Polymorphisms on the Prognosis of Lung Cancer Patients with Platinum-Based Chemotherapy

He J, Wang Z, Wang Y, Zou T, Li XP, Cao L, Chen J

Pharmacogenomics and Personalized Medicine 2021, 14:1193-1203

Published Date: 18 September 2021

The Effects of Gene Variations of GABRA2, GABRB1, GABRG2, GAD1 and SLC1A3 on Patients with Propofol During Anesthesia Induction

Zhang L, Zheng Z, Ma W, Zhang S, Xue F, Wang H, He Y, Ye F, Zhou S, Wen Y, Li X, Huang W, Huang M, Li J, Wang Z

Pharmacogenomics and Personalized Medicine 2021, 14:1185-1192

Published Date: 17 September 2021

DZIP1 Expression as a Prognostic Marker in Gastric Cancer: A Bioinformatics-Based Analysis

Liu YJ, Li JP, Zeng SH, Han M, Liu SL, Zou X

Pharmacogenomics and Personalized Medicine 2021, 14:1151-1168

Published Date: 16 September 2021

Gephyrin and CYP2C9 Genetic Polymorphisms in Patients with Pharmacoresistant Epilepsy

El-Tallawy HN, Abuhamdah S, Nassar AY, Farghaly WMA, Saleem TH, Atta SA, Sayed AA, Tohamy AM, Hassan MH

Pharmacogenomics and Personalized Medicine 2021, 14:1133-1140

Published Date: 9 September 2021

Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients

Boiko AS, Pozhidaev IV, Paderina DZ, Bocharova AV, Mednova IA, Fedorenko OY, Kornetova EG, Loonen AJM, Semke AV, Bokhan NA, Ivanova SA

Pharmacogenomics and Personalized Medicine 2021, 14:1123-1131

Published Date: 7 September 2021

Incidence and Risk Factors of Lower-Extremity Deep Vein Thrombosis After Thrombolysis Among Patients with Acute Ischemic Stroke

Liu Z, Liu D, Guo ZN, Jin H, Sun T, Ni C, Yan X

Pharmacogenomics and Personalized Medicine 2021, 14:1107-1114

Published Date: 4 September 2021

Interactive Association Between CYP2C9 rs2860905 Polymorphism and Atrial Fibrillation on Ischemic Stroke in Taiwan Biobank Participants

Peng JW, Nfor ON, Ho CC, Hsu SY, Lung CC, Tantoh DM, Chou MC, Liaw YP

Pharmacogenomics and Personalized Medicine 2021, 14:1087-1092

Published Date: 31 August 2021

Association of Genetic Variants in miR-217 Gene with Risk of Coronary Artery Disease: A Case–Control Study

Han X, Liang X, Wu M, Zhang L, Jiang H

Pharmacogenomics and Personalized Medicine 2021, 14:1081-1086

Published Date: 28 August 2021

Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management

Eljilany I, Elarref M, Shallik N, Elzouki AN, Bader L, El-Bardissy A, Abdelsamad O, Al-Badriyeh D, Cavallari LH, Elewa H

Pharmacogenomics and Personalized Medicine 2021, 14:1069-1080

Published Date: 28 August 2021

A Chinese Boy with Mowat–Wilson Syndrome Caused by a 10 bp Deletion in the ZEB2 Gene

Wei L, Han X, Li X, Han B, Nie W

Pharmacogenomics and Personalized Medicine 2021, 14:1041-1045

Published Date: 23 August 2021

Population Genetic Difference of Pharmacogenomic VIP Variants in the Tibetan Population

He C, Peng L, Xing S, Li D, Wang L, Jin T

Pharmacogenomics and Personalized Medicine 2021, 14:1027-1040

Published Date: 16 August 2021

Economic Impact of the Application of a Precision Medicine Model (5SPM) on Psychotic Patients

Carrascal-Laso L, Franco-Martín M, Marcos-Vadillo E, Ramos-Gallego I, García-Berrocal B, Mayor-Toranzo E, Sánchez-Iglesias S, Lorenzo C, Sevillano-Jiménez A, Sánchez-Martín A, García-Salgado MJ, Isidoro-García M

Pharmacogenomics and Personalized Medicine 2021, 14:1015-1025

Published Date: 16 August 2021

Long Non-Coding RNAs Gene Variants as Molecular Markers for Diabetic Retinopathy Risk and Response to Anti-VEGF Therapy

Mohammad HMF, Abdelghany AA, Al Ageeli E, Kattan SW, Hassan R, Toraih EA, Fawzy MS, Mokhtar N

Pharmacogenomics and Personalized Medicine 2021, 14:997-1014

Published Date: 14 August 2021

Genetic Variation of Inflammatory Genes to Ischemic Stroke Risk in a Chinese Han Population

Zhang Z, Mei Y, Xiong M, Lu F, Zhao X, Zhu J, He B

Pharmacogenomics and Personalized Medicine 2021, 14:977-986

Published Date: 13 August 2021

Individualized Drugs’ Selection by Evaluation of Drug Properties, Pharmacogenomics and Clinical Parameters: Performance of a Bioinformatic Tool Compared to a Clinically Established Counselling Process

Borro M, Gentile G, Preissner SH, Pomes LM, Gohlke BO, Del Casale A, Eckert A, Marchetti P, Preissner S, Preissner R, Simmaco M

Pharmacogenomics and Personalized Medicine 2021, 14:955-962

Published Date: 5 August 2021

Ovarian Sertoli-Leydig Cell Tumor, Multinodular Goiter, Cystic Nephromas and DICER1 Mutations: Case Report and Literature Review

Ni Y, Zhou X, Wu L, Wu P, Liu Y, Li Y, Cai L, Fu X, Zhang C

Pharmacogenomics and Personalized Medicine 2021, 14:947-953

Published Date: 3 August 2021

Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma

Dai T, Li J, Lu X, Ye L, Yu H, Zhang L, Deng M, Zhu S, Liu W, Wang G, Yang Y

Pharmacogenomics and Personalized Medicine 2021, 14:927-945

Published Date: 3 August 2021

Influence of SULT1A1*2 Polymorphism on Plasma Efavirenz Concentration in Thai HIV-1 Patients

Chamnanphon M, Sukprasong R, Gaedigk A, Manosuthi W, Chariyavilaskul P, Wittayalertpanya S, Koomdee N, Jantararoungtong T, Puangpetch A, Sukasem C

Pharmacogenomics and Personalized Medicine 2021, 14:915-926

Published Date: 24 July 2021

C5 Variant rs10985126 is Associated with Mortality in Patients with Symptomatic Coronary Artery Disease

Henes JK, Groga-Bada P, Schaeffeler E, Winter S, Hack L, Zdanyte M, Mueller K, Droppa M, Stimpfle F, Gawaz M, Langer H, Schwab M, Geisler T, Rath D

Pharmacogenomics and Personalized Medicine 2021, 14:893-903

Published Date: 21 July 2021

Independent Community Pharmacists’ Experience in Offering Pharmacogenetic Testing

Haga SB, Mills R, Moaddeb J, Liu Y, Voora D

Pharmacogenomics and Personalized Medicine 2021, 14:877-886

Published Date: 15 July 2021

Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV

Jin Y, Jin G, Zhao J, Jiang C, Zhao L, Jiang Y, Chen F, Li H, Wang W, Wu Y, Liu G, Li X, Gu M, Li X, Li Q

Pharmacogenomics and Personalized Medicine 2021, 14:867-875

Published Date: 15 July 2021

Bioinformatics Analysis of Neuroblastoma miRNA Based on GEO Data

Shi J, Zhang P, Su H, Cai L, Zhao L, Zhou H

Pharmacogenomics and Personalized Medicine 2021, 14:849-858

Published Date: 13 July 2021

Interactive Association Between Intronic Polymorphism (rs10506151) of the LRRK2 Gene and Type 2 Diabetes on Neurodegenerative Diseases

Huang MH, Liu YF, Nfor ON, Hsu SY, Lin WY, Chang YS, Liaw YP

Pharmacogenomics and Personalized Medicine 2021, 14:839-847

Published Date: 13 July 2021

Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis

Ma Z, Wang X, Lv Q, Gong Y, Xia M, Zhuang L, Lu X, Yang Y, Zhang W, Fu G, Ye Y, Lai D

Pharmacogenomics and Personalized Medicine 2021, 14:823-837

Published Date: 12 July 2021

Single-Nucleotide Polymorphisms Related to Leprosy Risk and Clinical Phenotypes Among Chinese Population

Long SY, Wang L, Jiang HQ, Shi Y, Zhang WY, Xiong JS, Sun PW, Chen YQ, Mei YM, Pan C, Ge G, Wang ZZ, Wu ZW, Yu MW, Wang HS

Pharmacogenomics and Personalized Medicine 2021, 14:813-821

Published Date: 12 July 2021

Delivery of Pharmacogenetic Testing with or without Medication Therapy Management in a Community Pharmacy Setting

Haga SB, Mills R, Moaddeb J, Liu Y, Voora D

Pharmacogenomics and Personalized Medicine 2021, 14:785-796

Published Date: 9 July 2021

Integrative DNA Methylation and Gene Expression Analysis of Cognitive Behavioral Therapy Response in Children and Adolescents with Obsessive-Compulsive Disorder; a Pilot Study

Rodriguez N, Martinez-Pinteño A, Blázquez A, Ortiz AE, Moreno E, Gassó P, Lafuente A, Lazaro L, Mas S

Pharmacogenomics and Personalized Medicine 2021, 14:757-766

Published Date: 29 June 2021

A Two-Stage Study Identifies Two Novel Polymorphisms in PRKAG2 Affecting Metformin Response in Chinese Type 2 Diabetes Patients

Xiao D, Liu JY, Zhang SM, Liu RR, Yin JY, Han XY, Li X, Zhang W, Chen XP, Zhou HH, Ji LN, Liu ZQ

Pharmacogenomics and Personalized Medicine 2021, 14:745-755

Published Date: 23 June 2021

Acetylator Status Among Newly Diagnosed and Recurrent Tuberculosis Patients from Kupang, Eastern Part of Indonesia

Sahiratmadja E, Rini IA, Penggoam S, Charles A, Maskoen AM, Parwati I

Pharmacogenomics and Personalized Medicine 2021, 14:737-744

Published Date: 22 June 2021

The Phenomenon of Gene Rearrangement is Frequently Associated with TP53 Mutations and Poor Disease-Free Survival in Hepatocellular Carcinoma

He F, Song K, Guan G, Huo J, Xin Y, Li T, Liu C, Zhu Q, Fan N, Guo Y, Wu L

Pharmacogenomics and Personalized Medicine 2021, 14:723-736

Published Date: 21 June 2021

Physicians’ Knowledge and Attitudes Regarding Point-of-Care Pharmacogenetic Testing: A Hospital-Based Cross-Sectional Study

Muflih S, Alshogran OY, Al-Azzam S, Al-Taani G, Khader YS

Pharmacogenomics and Personalized Medicine 2021, 14:655-665

Published Date: 1 June 2021

Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview

Svob Strac D, Konjevod M, Sagud M, Nikolac Perkovic M, Nedic Erjavec G, Vuic B, Simic G, Vukic V, Mimica N, Pivac N

Pharmacogenomics and Personalized Medicine 2021, 14:631-653

Published Date: 28 May 2021

Angiotensin System Polymorphisms’ in SARS-CoV-2 Positive Patients: Assessment Between Symptomatic and Asymptomatic Patients: A Pilot Study

Cafiero C, Rosapepe F, Palmirotta R, Re A, Ottaiano MP, Benincasa G, Perone R, Varriale E, D'Amato G, Cacciamani A, Micera A, Pisconti S

Pharmacogenomics and Personalized Medicine 2021, 14:621-629

Published Date: 27 May 2021

Ferroptosis-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Diffuse Large B-Cell Lymphoma

Chen H, He Y, Pan T, Zeng R, Li Y, Chen S, Li Y, Xiao L, Zhou H

Pharmacogenomics and Personalized Medicine 2021, 14:609-619

Published Date: 26 May 2021

Association of HMGA2 Polymorphisms with Glioma Susceptibility in Chinese Children

Zhou J, Wang P, Zhang R, Huang X, Dai H, Yuan L, Ruan J

Pharmacogenomics and Personalized Medicine 2021, 14:601-607

Published Date: 25 May 2021

CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance

Qiao LY, Li HB, Zhang Y, Shen D, Liu P, Che YQ

Pharmacogenomics and Personalized Medicine 2021, 14:591-599

Published Date: 25 May 2021

Trigger-Specific Remodeling of KCa2 Potassium Channels in Models of Atrial Fibrillation

Rahm AK, Gramlich D, Wieder T, Müller ME, Schoeffel A, El Tahry FA, Most P, Heimberger T, Sandke S, Weis T, Ullrich ND, Korff T, Lugenbiel P, Katus HA, Thomas D

Pharmacogenomics and Personalized Medicine 2021, 14:579-590

Published Date: 20 May 2021

Genetic Association Study Revealed Three Loci Were Associated Risk of Myopia Among Minors

Zhou Z, Li S, Yang Q, Yang X, Hao K, Liu Y, Xu S

Pharmacogenomics and Personalized Medicine 2021, 14:547-551

Published Date: 11 May 2021

Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]

Takahashi PY, Ryu E, Cerhan JR, Bielinski SJ, Olson JE

Pharmacogenomics and Personalized Medicine 2021, 14:545-546

Published Date: 6 May 2021

BRCA2 3ʹ-UTR Polymorphism rs15869 Alters Susceptibility to Papillary Thyroid Carcinoma via Binding hsa-mir-1178-3p

Guo N, Qu P, Li H, Liu L, Jin H, Liu R, Zhang Z, Zhang X, Li Y, Lu X, Zhao Y

Pharmacogenomics and Personalized Medicine 2021, 14:533-544

Published Date: 6 May 2021

Digital PCR Detection of mtDNA/gDNA Ratio in Embryo Culture Medium for Prediction of Embryo Development Potential

Zhang Q, Ji H, Shi J, Wang L, Ding L, Jiang Y, Huang X, Qiu Snr P, Li P

Pharmacogenomics and Personalized Medicine 2021, 14:521-531

Published Date: 30 April 2021

Evaluation of CYP2C19 Gene Polymorphisms in Patients with Acid Peptic Disorders Treated with Esomeprazole

Díaz-Ordóñez L, Ramírez-Montaño D, Candelo E, González-Restrepo C, Silva-Peña S, Rojas CA, Sepulveda Copete M, Echavarria HR, Pachajoa H

Pharmacogenomics and Personalized Medicine 2021, 14:509-520

Published Date: 29 April 2021

Reversal of Chemotherapy Resistance to Cisplatin in NSCLC by miRNA-195-5p via Targeting the FGF2 Gene

Wang H, Sui Z, Wu X, Tang P, Zhang H, Yu Z

Pharmacogenomics and Personalized Medicine 2021, 14:497-508

Published Date: 28 April 2021

The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects

Liu Y, Yang C, Qi W, Pei Z, Xue W, Zhu H, Dong M, Guo Y, Cong D, Wang F

Pharmacogenomics and Personalized Medicine 2021, 14:477-485

Published Date: 23 April 2021

DNA Methylation of Fluoxetine Response in Child and Adolescence: Preliminary Results

Martinez-Pinteño A, Rodriguez N, Blázquez A, Plana MT, Varela E, Gassó P, Lafuente A, Lazaro L, Mas S

Pharmacogenomics and Personalized Medicine 2021, 14:459-467

Published Date: 19 April 2021

CSF1R is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in the Gastric Cancer Microenvironment

Chen D, Xiong L, Zhang L, Yu H, Xu Y, Wang M, Jiang X, Xiong Z

Pharmacogenomics and Personalized Medicine 2021, 14:445-457

Published Date: 13 April 2021

CYP2C9*3/*3 Gene Expression Affects the Total and Free Concentrations of Valproic Acid in Pediatric Patients with Epilepsy

Wu X, Dong W, Li H, Yang X, Jin Y, Zhang Z, Jiang Y

Pharmacogenomics and Personalized Medicine 2021, 14:417-430

Published Date: 9 April 2021

Non-Classical 21-Hydroxylase Deficiency: Analysis of a Mutant Gene in a Uyghur Family and Literature Review

Maimaitiming J, Amuti G, TuHuTi A, Chen Y, Song XX, Wang J, Alimu A, Zhang K, Abudounaiyimu M, Jiang J, Wang XL, Guo YY

Pharmacogenomics and Personalized Medicine 2021, 14:409-416

Published Date: 7 April 2021

CHN1 is a Novel Prognostic Marker for Diffuse Large B-Cell Lymphoma

Sun J, Zhu X, Zhao Y, Zhou Q, Qi R, Liu H

Pharmacogenomics and Personalized Medicine 2021, 14:397-408

Published Date: 1 April 2021

Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana [Corrigendum]

Maseng MJ, Tawe L, Thami PK, Seatla KK, Moyo S, Martinelli A, Kasvosve I, Novitsky V, Essex M, Russo G, Gaseitsiwe S, Paganotti GM

Pharmacogenomics and Personalized Medicine 2021, 14:395-396

Published Date: 31 March 2021

Correlation Study on HLA-DR and CD117 (c-Kit) Expressions: Its Prognosis and Treatment Response in Acute Myeloid Leukemia Patients

El-Meligui YM, Abd Elrhman HE, Salahuddin A, Hamouda MA, Kassem AB

Pharmacogenomics and Personalized Medicine 2021, 14:381-393

Published Date: 30 March 2021

Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen

Zhu X, Zhu J, Sun F, Zhen Z, Zhou D, Lu S, Huang J, Que Y, Zhang L, Cai R, Wang J, Zhang Y

Pharmacogenomics and Personalized Medicine 2021, 14:369-377

Published Date: 23 March 2021

Skeletal Abnormalities and VDR1 Gene Polymorphisms in Mucopolysaccharidosis Patients

Alkhzouz C, Cabau G, Lazea C, Asavoaie C, Bucerzan S, Mirea AM, Farcas M, Miclaus M Jnr, Popp R, Miclea D

Pharmacogenomics and Personalized Medicine 2021, 14:349-358

Published Date: 17 March 2021

Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana

Maseng MJ, Tawe L, Thami PK, Seatla KK, Moyo S, Martinelli A, Kasvosve I, Novitsky V, Essex M, Russo G, Gaseitsiwe S, Paganotti GM

Pharmacogenomics and Personalized Medicine 2021, 14:335-347

Published Date: 16 March 2021

Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer

Pacini L, Jenks AD, Vyse S, Wilding CP, Arthur A, Huang PH

Pharmacogenomics and Personalized Medicine 2021, 14:301-317

Published Date: 9 March 2021

Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions

Jeiziner C, Stäuble CK, Lampert ML, Hersberger KE, Meyer zu Schwabedissen HE

Pharmacogenomics and Personalized Medicine 2021, 14:279-286

Published Date: 19 February 2021

TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy

Song K, He F, Xin Y, Guan G, Huo J, Zhu Q, Fan N, Guo Y, Zang Y, Wu L

Pharmacogenomics and Personalized Medicine 2021, 14:269-278

Published Date: 16 February 2021

Relevance of PD-L1 Non-Coding Polymorphisms on the Prognosis of a Genetically Admixed NSCLC Cohort

Machado-Rugolo J, Gutierrez Prieto T, Fabro AT, Parra Cuentas ER, Sá VK, Baldavira CM, Rainho CA, Castelli EC, Farhat C, Takagaki TY, Nagai MA, Capelozzi VL

Pharmacogenomics and Personalized Medicine 2021, 14:239-252

Published Date: 15 February 2021

No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study

Takahashi PY, Ryu E, Bielinski SJ, Hathcock M, Jenkins GD, Cerhan JR, Olson JE

Pharmacogenomics and Personalized Medicine 2021, 14:229-237

Published Date: 11 February 2021

Identification of Crucial Genes and Pathways Associated with Atherosclerotic Plaque in Diabetic Patients

Li YY, Zhang S, Wang H, Zhang SX, Xu T, Chen SW, Zhang Y, Chen Y

Pharmacogenomics and Personalized Medicine 2021, 14:211-220

Published Date: 4 February 2021

TPMT Genetic Variability and Its Association with Hematotoxicity in Indonesian Children with Acute Lymphoblastic Leukemia in Maintenance Therapy

Rosdiana DS, Setiabudy R, Andalusia R, Gatot D, Louisa M, Bardosono S, Instiaty I

Pharmacogenomics and Personalized Medicine 2021, 14:199-210

Published Date: 3 February 2021

Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension

Liang H, Zhang X, Ma Z, Sun Y, Shu C, Zhu Y, Zhang Y, Hu S, Fu X, Liu L

Pharmacogenomics and Personalized Medicine 2021, 14:189-197

Published Date: 2 February 2021

Assessment of the Role of Selected SMAD3 and SMAD4 Genes Polymorphisms in the Development of Colorectal Cancer: Preliminary Research

Wosiak A, Wodziński D, Michalska K, Pietrzak J, Kordek R, Balcerczak E

Pharmacogenomics and Personalized Medicine 2021, 14:167-178

Published Date: 29 January 2021

Relationship Between Interleukin-6 −174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients

Sokolik R, Iwaszko M, Świerkot J, Wysoczańska B, Korman L, Wiland P, Bogunia-Kubik K

Pharmacogenomics and Personalized Medicine 2021, 14:157-166

Published Date: 28 January 2021

Genetic Polymorphism Effect on Warfarin–Rifampin Interaction: A Case Report and Review of Literature

Salem M, Eljilany I, El-Bardissy A, Elewa H

Pharmacogenomics and Personalized Medicine 2021, 14:149-156

Published Date: 26 January 2021

CYP2C9 Variations and Their Pharmacogenetic Implications Among Diverse South Asian Populations

Nizamuddin S, Dubey S, Singh S, Sharma S, Machha P, Thangaraj K

Pharmacogenomics and Personalized Medicine 2021, 14:135-147

Published Date: 27 January 2021

Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon

Fernandes MR, Rodrigues JCG, Maroñas O, Latorre-Pellicer A, Cruz R, Guerreiro JF, Burbano RMR, Assumpção PP, Ribeiro-dos-Santos A, Santos SEB, Carracedo A, Santos NPC

Pharmacogenomics and Personalized Medicine 2021, 14:117-133

Published Date: 22 January 2021

No Association Between FTO Gene Polymorphisms and Central Nervous System Tumor Susceptibility in Chinese Children

Liao Y, Yuan L, Zhang Z, Lin A, Zhou J, Zhuo Z, Zhao J

Pharmacogenomics and Personalized Medicine 2021, 14:109-115

Published Date: 19 January 2021

STAT6 rs324015 Gene Polymorphism Increases Ulcerative Colitis Risk: A Case–Control Study

Dai L, Zhang D, Qian Y, Wan Y, Chang S, Qian H

Pharmacogenomics and Personalized Medicine 2021, 14:101-107

Published Date: 19 January 2021

High LARGE1 Expression May Predict Benefit from Adjuvant Chemotherapy in Resected Non-Small-Cell Lung Cancer

Liu Y, Huang S, Kuang M, Wang H, Xie Q

Pharmacogenomics and Personalized Medicine 2021, 14:87-99

Published Date: 18 January 2021

Genetic Interaction of H19 and TGFBR1 Polymorphisms with Risk of Epilepsy in a Chinese Population

Zheng Z, Yan Y, Guo Q, Wang L, Han X, Liu S

Pharmacogenomics and Personalized Medicine 2021, 14:77-86

Published Date: 14 January 2021

Review on Databases and Bioinformatic Approaches on Pharmacogenomics of Adverse Drug Reactions

Tong H, Phan NVT, Nguyen TT, Nguyen DV, Vo NS, Le L

Pharmacogenomics and Personalized Medicine 2021, 14:61-75

Published Date: 13 January 2021

Genetic Variants of the MIF Gene and Susceptibility of Rectal Cancer

Chuo D, Lin D, Yin M, Chen Y

Pharmacogenomics and Personalized Medicine 2021, 14:55-60

Published Date: 12 January 2021

Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment

Yao Y, Zhang T, Qi L, Liu R, Liu G, Li J, Sun C

Pharmacogenomics and Personalized Medicine 2021, 14:15-26

Published Date: 8 January 2021

Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin

Srisawasdi P, Rodcharoen P, Vanavanan S, Chittamma A, Sukasem C, Na nakorn C, Dejthevaporn C, Kroll MH

Pharmacogenomics and Personalized Medicine 2021, 14:1-13

Published Date: 6 January 2021